Mark Hyman on Comprehensive Biomarker Testing: recommends

Through Function Health, Hyman promotes comprehensive lab testing — 160-plus panels per the company’s description — including advanced cardiovascular markers such as apolipoprotein B, which Function presents as a better predictor of heart risk than standard LDL. Hyman describes the offering as roughly five times a standard physical.

His stated reasoning is that earlier and deeper measurement enables earlier disease detection and prevention, consistent with his functional-medicine emphasis on finding root causes before symptoms appear. This position is also the most commercially entangled of his recommendations: Hyman is co-founder and CMO of Function Health, and Public Citizen’s “MAHA, Means, Money” report raised conflict-of-interest questions about his supplement recommendations tied to Function Health test results. That criticism is noted here as part of the site’s for-and-against coverage. (Hyman’s position; not this site’s medical advice.)

This page chronicles a stated position of the person above. It is not medical advice and not the site's own conclusion.